Companies · Other Health Care

Acquisition Glacier II Inc.

WESTMOUNT · Other Health Care

Diligence memoA one-page analyst read on Acquisition Glacier II Inc. — recommendation, valuation, rhythm, risks.
$5.3M
Total raised · real
3
Rounds
0.6×
Latest step-up
Top 36%
Sector rank · raised
Seed
Latest stage · inferred · Sat Jul 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Acquisition Glacier II Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.84× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era.
  • Within the normal band (84% of peer median) for its niche.
Dormant
  • Last raise 9.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Acquisition Glacier II Inc. is one of 5376 Other Health Care companies tracked from WESTMOUNT. By capital raised it ranks mid-pack (ahead of 65% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$100M+
Issuer revenue
Rule 506(b)
Reg D exemption
1
Investors (latest)
2013
Year incorporated
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2014-07-08 Raised $1.4M (real) Modeled valuation $36M (est)Seed2014Seed · 2014-07-08 Raised $1.9M (real) Modeled valuation $46M (est)Seed2014Seed · 2014-07-08 Raised $1.9M (real) Modeled valuation $48M (est)Seed2014Seed · 2014-07-08 Raised $1.9M (real) Modeled valuation $48M (est)Seed2014Seed · 2014-07-08 Raised $1.4M (real) Modeled valuation $36M (est)Seed2014Seed · 2016-07-01 Raised $893K (real) Modeled valuation $22M (est)Seed2016Seed · 2016-07-01 Raised $893K (real) Modeled valuation $22M (est)Seed2016Seed · 2016-07-01 Raised $1.5M (real) Modeled valuation $37M (est)Seed2016Seed · 2017-03-15 Raised $2.4M (real) Modeled valuation $59M (est)Seed2017Seed · 2017-07-01 Raised $1.5M (real) Modeled valuation $37M (est)Seed2017+$1.9M+$1.9M+$1.9M+$1.4M+$893K+$893K+$1.5M+$2.4M+$1.5MCumulative $16M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.4M · 2014
Seed extension$1.9M · 2014
Seed extension$1.9M · 2014
Seed extension$1.9M · 2014
Seed extension$1.4M · 2014
Seed extension$893K · 2016
Seed extension$893K · 2016
Seed extension$1.5M · 2016
Seed extension$2.4M · 2017
Seed extension$1.5M · 2017

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$37.2M
Base estimate est.
$1.3M
Conservative case
$291.8M
Upside case
$7.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $35.9M · 2014-07-082014Seed · modeled $46.5M · 2014-07-08Seed · modeled $48.2M · 2014-07-08Seed · modeled $48.2M · 2014-07-08Seed · modeled $35.9M · 2014-07-08Seed · modeled $22.1M · 2016-07-01Seed · modeled $22.1M · 2016-07-01Seed · modeled $37.2M · 2016-07-01Seed · modeled $58.7M · 2017-03-15Seed · modeled $37.2M · 2017-07-012017
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
9.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
4 mo
Avg between rounds
$1.8M/yr
Capital velocity
12.0 yr
On record since
2014
First round
10
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.2× above median
This company$5.3M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.9× of median
This company$1.5M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 1.7× above median
This company$37.2M
Sector median$22.1M

Raised more than 65% of sector peers (real $). Modeled value above 63% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #126 of 222.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Eye Academy of America Ltd. · Seed Raised $4.0M · modeled $99.1M (est)Guest House Holdings, LLC · Seed Raised $4.0M · modeled $99.1M (est)Cb Therapeutics Inc. · Seed Raised $4.0M · modeled $99.1M (est)Ruddco Inc. · Seed Raised $4.0M · modeled $99.1M (est)Shift Sciences, LLC · Seed Raised $4.0M · modeled $98.6M (est)BHCP OK4 HH/H Investors, LLC · Seed Raised $4.0M · modeled $97.9M (est)ReNovo, Inc. · Seed Raised $4.0M · modeled $97.9M (est)CCRC of Lenexa, LLC · Seed Raised $3.9M · modeled $97.6M (est)Nocira, Llc · Seed Raised $3.9M · modeled $96.7M (est)PureFlowCath, LLC · Seed Raised $3.8M · modeled $94.6M (est)Prevent Biometrics, Inc. · Seed Raised $4.2M · modeled $94.2M (est)Medal, Inc. · Seed Raised $3.8M · modeled $93.6M (est)Acquisition Glacier II Inc. (this company) Raised $5.3M · modeled $37.2M (est)Acquisition Glacier II Inc.
CompanyStageRaised · realValue · estvs peer med.
Eye Academy of America Ltd.Seed$4.0M$99.1M2.23×
Guest House Holdings, LLCSeed$4.0M$99.1M2.23×
Cb Therapeutics Inc.Seed$4.0M$99.1M2.23×
Ruddco Inc.Seed$4.0M$99.1M2.23×
Shift Sciences, LLCSeed$4.0M$98.6M2.22×
BHCP OK4 HH/H Investors, LLCSeed$4.0M$97.9M2.21×
ReNovo, Inc.Seed$4.0M$97.9M2.21×
CCRC of Lenexa, LLCSeed$3.9M$97.6M2.20×
Nocira, LlcSeed$3.9M$96.7M2.18×
PureFlowCath, LLCSeed$3.8M$94.6M2.13×
Prevent Biometrics, Inc.Seed$4.2M$94.2M2.12×
Medal, Inc.Seed$3.8M$93.6M2.11×
Acquisition Glacier II Inc. this companySeed$5.3M$37.2M0.84×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.4M2014-07-08$7.3M$35.9M85%
Seed$1.9M2014-07-08$9.4M$46.5M85%
Seed$1.9M2014-07-08$9.7M$48.2M85%
Seed$1.9M2014-07-08$9.7M$48.2M90%
Seed$1.4M2014-07-08$7.3M$35.9M85%
Seed$893K2016-07-01$4.5M$22.1M85%
Seed$893K2016-07-01$4.5M$22.1M85%
Seed$1.5M2016-07-01$7.5M$37.2M85%
Seed$2.4M2017-03-15$11.8M$58.7M90%
Seed$1.5M2017-07-01$7.5M$37.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.4M2014-07-08
    • First recorded raise — entered as Seed.
    • 8 investors on this round.
  2. Seed$1.9M2014-07-08
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 10 investors on this round.
  3. Seed$1.9M2014-07-08
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 14 investors on this round.
  4. Seed$1.9M2014-07-08
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 14 investors on this round.
  5. Seed$1.4M2014-07-08
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 6 investors on this round.
  6. Seed$893K2016-07-01
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  7. Seed$893K2016-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  8. Seed$1.5M2016-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× larger than the prior — scaling up.
    • 1 investor on this round.
  9. Seed$2.4M2017-03-15
    • Raised 8 mo later, in step with the ~14 mo sector norm.
    • Round 1.6× larger than the prior — scaling up.
    • 1 investor on this round.
  10. Seed$1.5M2017-07-01
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2017 ~Q4
Modeled next raise · ~4mo cadence
$1.5M
Modeled next size est.range $1.5M$2.4M
0.6×
Last step-up
$1.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
John Coyle7 other2014-07
Alan Quasha3 other2016-07
Laura O'Donnell3 other2014-07
Gary Saage2 other2016-07
Henry Minello2 other2014-07
Josua Malherbe2 other2016-07
Alain Dominique Perrin1 other2016-07
Bernard Fornas1 other2016-07
Brian Edwards1 other2014-07
Eric Bouchard1 other2014-07
Jurgen Schrempp1 other2016-07
Maria Ramos1 other2016-07
Ruggero Magnoni1 other2016-07
Simon Marc1 other2014-07
Simon Murray1 other2016-07
David Torralbo2014-07
Jacques Bougie2014-07
Mario Paradis2014-07
Peter Luther2014-07
W. Brian Edwards2014-07
Yvon Bolduc2014-07
Registry & provenance

Acquisition Glacier II Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1614111
SEC CIK
2013
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Compagnie Financiere Richemont SaManufacturingSeries B$42.4M$29.4Mnetwork9 shared operators
Lyo Lux Holdings, Inc.Other Health CareSeries B$24.9M$544.5Mnetwork2 shared operators · same sector
Zenith Technical Innovations, LLCOther Health CareSeed$5.3M$37.2Msame sector · same stage
Ikonisys IncOther Health CareSeed$5.2M$35.6Msame sector · same stage
IR-Med, Inc.Other Health CareSeed$5.4M$36.9Msame sector · same stage
Doctor Evidence LLCOther Health CareSeed$5.5M$37.2Msame sector · same stage
Wellview, Inc.Other Health CareSeed$5.5M$38.1Msame sector · same stage
Enforcer eCoaching, Inc.Other Health CareSeed$5.1M$39.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
GHR Acquisition, LLCOther Health CareSeries B$123.9M82%
DBN BCS II Investments, LLCOther Health CareSeed$34.0M80%
Pan-Am Acquisition, LLCOther Health CareSeed$9.3M80%
2GHealth Inc.Other Health CareSeries A$35.6M80%
DAV Acquisition Corp.Other Health CarePre-Seed$15.4M80%
Apollo Med Innovations, Inc.Other Health CarePre-Seed$2.6M80%
Artis Holdings, LLCOther Health CareSeries B$383.2M79%
Arthron Investments, LLCOther Health CarePre-Seed$1.2M79%
Frequently asked
How much funding has Acquisition Glacier II Inc. raised?
Acquisition Glacier II Inc. has raised approximately $5.3M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Acquisition Glacier II Inc.'s estimated valuation?
Provath's modeled valuation for Acquisition Glacier II Inc. is approximately $37.2M (modeled range $1.3M–$291.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Acquisition Glacier II Inc. at?
Acquisition Glacier II Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Sat Jul 01.
What does Acquisition Glacier II Inc. do and where is it based?
Acquisition Glacier II Inc. operates in the Other Health Care sector, based in WESTMOUNT.
Explore related

See where Acquisition Glacier II Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Acquisition Glacier II Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.